WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | -3.60%4.33B | -3.33%3.45B | -4.04%2.06B | -20.74%491.45M | 20.01%4.49B | 6.52%3.57B | 2.44%2.15B | 21.33%620.08M | -4.36%3.74B | 7.44%3.35B |
Operating revenue | -3.60%4.33B | -3.33%3.45B | -4.04%2.06B | -20.74%491.45M | 20.01%4.49B | 6.52%3.57B | 2.44%2.15B | 21.33%620.08M | -4.36%3.74B | 7.44%3.35B |
Other operating revenue | 46.42%58.45M | ---- | -15.69%31.19M | ---- | -15.17%39.92M | ---- | -8.40%37M | ---- | 8.82%47.06M | ---- |
Total operating cost | -0.70%3.87B | 0.85%2.99B | -1.37%1.81B | -18.07%504.28M | 17.42%3.89B | 3.71%2.97B | 2.43%1.83B | 23.26%615.52M | 0.14%3.31B | 10.78%2.86B |
Operating cost | -2.00%3.31B | -0.66%2.62B | -3.23%1.6B | -21.33%426.26M | 22.92%3.38B | 3.64%2.64B | 4.49%1.66B | 28.74%541.82M | -2.42%2.75B | 14.38%2.55B |
Operating tax surcharges | -0.55%57.93M | 2.93%52.36M | 8.75%28.28M | 11.05%14.97M | 7.27%58.25M | -1.28%50.87M | -7.06%26M | -4.95%13.48M | -8.34%54.3M | -2.32%51.53M |
Operating expense | -9.51%27.34M | -18.79%20.13M | -46.86%9.9M | -5.99%3.46M | 14.83%30.21M | -18.14%24.79M | -26.28%18.63M | -28.12%3.68M | -7.81%26.31M | -9.66%30.28M |
Administration expense | 7.13%333.66M | 5.29%183.56M | -1.12%103.86M | 5.78%47.93M | 1.42%311.45M | -1.63%174.35M | -6.52%105.04M | 14.96%45.31M | -5.24%307.08M | -13.61%177.23M |
Financial expense | 3.31%32.99M | -11.18%21.88M | -30.16%14.09M | -38.02%6.96M | -58.87%31.93M | -56.59%24.63M | -49.24%20.18M | -43.27%11.23M | -6.66%77.64M | -14.08%56.75M |
-Interest expense (Financial expense) | -8.38%50.56M | -15.00%37.11M | -7.55%26.76M | -27.61%13.15M | -38.47%55.18M | -35.86%43.66M | -36.89%28.94M | -15.20%18.17M | -6.10%89.68M | -5.21%68.07M |
-Interest Income (Financial expense) | 36.72%-16.78M | 33.85%-14.68M | -1.61%-12.08M | 10.38%-6.24M | -87.25%-26.52M | -100.60%-22.19M | -104.33%-11.89M | -217.84%-6.97M | -26.22%-14.16M | -22.04%-11.06M |
Research and development | 23.91%103.82M | 71.73%93.69M | 528.48%50.07M | --4.7M | -18.17%83.79M | --54.56M | --7.97M | ---- | --102.4M | ---- |
Credit Impairment Loss | -172.79%-5.07M | -128.33%-7.32M | -174.45%-7.64M | -66.13%2.2M | 137.56%6.97M | 0.37%-3.21M | -193.75%-2.78M | 358.02%6.5M | 52.32%-18.55M | 64.64%-3.22M |
Asset Impairment Loss | -30.05%-87.35M | -49.96%-56.47M | -22.78%-19.61M | 31.78%-5.76M | -13.03%-67.17M | -21.60%-37.66M | 6.02%-15.98M | -476.56%-8.45M | 51.03%-59.43M | 59.75%-30.97M |
Other net revenue | -61.44%34M | 4.27%41.94M | 6.58%18.63M | -84.30%1.1M | 59.83%88.19M | 224.01%40.23M | 63.76%17.48M | 190.96%7M | 186.99%55.18M | 125.29%12.42M |
Invest income | -9.52%37.29M | 92.28%31.39M | 240.77%5.96M | ---- | 7.75%41.21M | 104.62%16.33M | -46.90%-4.23M | 15.98%-9.16M | 243.87%38.25M | 347.85%7.98M |
-Including: Investment income associates | -37.15%25.83M | ---- | ---- | ---- | 14.50%41.1M | ---- | ---- | ---- | 251.12%35.9M | ---- |
Asset deal income | 5,252.35%29.23M | 9,962.05%32.1M | 17,874.77%29.78M | -257.66%-460.4K | -98.70%546.14K | 224.20%319.06K | 286.75%165.66K | -67.72%292.03K | 2,886.37%41.97M | -184.06%-256.89K |
Other revenue | -43.82%59.91M | -34.46%42.24M | -74.83%10.14M | -71.24%5.12M | 101.45%106.64M | 65.75%64.44M | 45.63%40.3M | 183.27%17.81M | -37.21%52.93M | 11.50%38.88M |
Operating profit | -27.50%496.92M | -22.07%503.37M | -18.39%267.96M | -201.58%-11.74M | 42.43%685.42M | 27.80%645.91M | 4.58%328.35M | 188.95%11.56M | -10.53%481.23M | 3.17%505.41M |
Add:Non operating Income | -30.88%9.61M | -37.01%6.96M | -61.50%3.02M | 12.59%1.17M | -42.64%13.9M | -46.06%11.04M | -58.98%7.84M | -9.50%1.04M | 44.67%24.24M | 71.58%20.47M |
Less:Non operating expense | -59.38%50.56M | -85.76%2.96M | 225.58%2.41M | 746.12%1.44M | 1,012.75%124.47M | 36.83%20.81M | -94.42%740.16K | -80.11%169.78K | -91.24%11.19M | -87.40%15.21M |
Total profit | -20.68%455.97M | -20.24%507.36M | -19.94%268.57M | -196.61%-12M | 16.30%574.86M | 24.57%636.15M | 4.88%335.45M | 189.36%12.42M | 15.76%494.29M | 34.00%510.67M |
Less:Income tax cost | 16.04%95.95M | -3.76%89.3M | 7.61%51.53M | 91.83%7.9M | 13.51%82.69M | 6.75%92.79M | -7.39%47.88M | 106.01%4.12M | -36.63%72.84M | -10.76%86.92M |
Net profit | -26.85%360.02M | -23.06%418.06M | -24.53%217.04M | -339.73%-19.91M | 16.78%492.17M | 28.23%543.36M | 7.25%287.57M | 262.04%8.3M | 35.06%421.44M | 49.37%423.75M |
Net profit from continuing operation | -26.85%360.02M | -23.06%418.06M | -24.53%217.04M | -339.73%-19.91M | 16.78%492.17M | 28.23%543.36M | 7.25%287.57M | 262.04%8.3M | 35.06%421.44M | 49.37%423.75M |
Less:Minority Profit | -77.93%6.35M | -64.29%12.5M | -90.39%1.82M | -582.50%-5.89M | 383.70%28.79M | 39.08%34.99M | 9.01%18.98M | 650.68%1.22M | 305.64%5.95M | 79.42%25.16M |
Net profit of parent company owners | -23.68%353.67M | -20.22%405.57M | -19.87%215.22M | -297.87%-14.01M | 11.53%463.38M | 27.54%508.37M | 7.13%268.59M | 181.57%7.08M | 31.93%415.49M | 47.81%398.59M |
Earning per share | ||||||||||
Basic earning per share | -24.14%0.22 | -20.19%0.253 | -23.86%0.134 | -295.65%-0.009 | -3.33%0.29 | 98.13%0.317 | 0.57%0.176 | 130.00%0.0046 | 30.43%0.3 | -18.37%0.16 |
Diluted earning per share | -24.14%0.22 | -20.19%0.253 | -23.86%0.134 | -295.65%-0.009 | -3.33%0.29 | 98.13%0.317 | 0.57%0.176 | 130.00%0.0046 | 30.43%0.3 | -18.37%0.16 |
Other composite income | ||||||||||
Total composite income | -26.85%360.02M | -23.06%418.06M | -24.53%217.04M | -339.73%-19.91M | 16.78%492.17M | 28.23%543.36M | 7.25%287.57M | 262.04%8.3M | 35.06%421.44M | 49.37%423.75M |
Total composite income of parent company owners | -23.68%353.67M | -20.22%405.57M | -19.87%215.22M | -297.87%-14.01M | 11.53%463.38M | 27.54%508.37M | 7.13%268.59M | 181.57%7.08M | 31.93%415.49M | 47.81%398.59M |
Total composite income of minority owners | -77.93%6.35M | -64.29%12.5M | -90.39%1.82M | -582.50%-5.89M | 383.70%28.79M | 39.08%34.99M | 9.01%18.98M | 650.68%1.22M | 305.64%5.95M | 79.42%25.16M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.